Innovation In Phase 1 Clinical Development June 25

Innovation In Phase 1 Clinical Development June 25

Main Category: Conferences
Article Date: 01 May 2012 - 7:00 PDT

email to a friend   printer friendly   opinions   <!-- rate article

Patient / Public:

Healthcare Prof:

Reducing Costs of Your Studies Eliminating Errors for a Smooth Transition to Phase 2 Development

While several strategies, such as outsourcing and strategic partnerships, have been tried and tested, there has been no definitive answer to resolve the financial dilemma that exists within clinical trials.

Attend Innovation in Phase 1 Clinical Development to hear successful implementations of cost saving strategies. This phase 1 clinical trial event will help you transition to Phase 2 production faster and more cost effectively.

You will hear case studies from the top pharmaceutical and biotech companies including Pfizer, Merck, GlaxoSmithKline, Bristol Meyers Squibb, Takeda Global RD, Abbott Laboratories and more. The presentations will teach you about:

• New one platform technologies that have been proven to improve efficiency and decrease errors by effectively storing and maintaining data obtained during your research phase

• Mitigating the impact of the User Fee Legislation and other FDA guidelines that will affect your organization

• The necessary project management skills your employees need in order to improve on internal practices used to select the optimal population for phase 1 clinical trials

• The importance of recruitment and retention of populations and long term sequestered studies

• Biomarkers and working with pharmaceutical companies who have been averse to disclosing pertinent information

• Strategies that will attract funding from new big Pharma venture capital arms for current and future research studies

Visit http://bit.ly/IQ7eyY to view the brochure or to register.

• Additional
• References
• Citations

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

---

APA

---

Please note: If no author information is provided, the source is cited instead.

---

Add Your Opinion On This Article

'Innovation In Phase 1 Clinical Development June 25 - 27, 2012 Boston, MA'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.